These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 4915040)
1. Synthesis of showdomycin. Kalvoda L; Farkas J; Sorm F Tetrahedron Lett; 1970 Jun; (26):2297-300. PubMed ID: 4915040 [No Abstract] [Full Text] [Related]
2. Transport studies of showdomycin, nucleosides and sugars in Escherichia coli B and in showdomycin-resistant mutants. Roy-Burman S; Visser DW Biochim Biophys Acta; 1972 Sep; 282(1):383-92. PubMed ID: 4560820 [No Abstract] [Full Text] [Related]
3. Some chemical and biological characteristics of showdomycin. Titani Y; Tsuruta Y J Antibiot (Tokyo); 1974 Dec; 27(12):956-62. PubMed ID: 4619627 [No Abstract] [Full Text] [Related]
4. Enhancement of the lethal effect of alkylation to Escherichia coli B-r by showdomycin. Chitani Y; Katsube Y J Antibiot (Tokyo); 1970 Jan; 23(1):43-4. PubMed ID: 4906632 [No Abstract] [Full Text] [Related]
5. Reversal of inhibiting action of showdomycin on the proliferation of Escherichia coli by nucleosides and thiol compounds. Nishimura H; Komatsu Y J Antibiot (Tokyo); 1968 Apr; 21(4):250-4. PubMed ID: 4876578 [No Abstract] [Full Text] [Related]
6. Showdomycin analogues: synthesis and antitumor evaluation. Numao N; Hemmi H; Naujokaitis SA; Rabinovitz M; Beisler JA J Med Chem; 1981 May; 24(5):515-20. PubMed ID: 7241509 [TBL] [Abstract][Full Text] [Related]
7. [Comparative study of the interaction of rubomycin B2 and rubomycin C with DNA in vitro]. Dorozhĭnskiĭ VB Antibiotiki; 1968 Mar; 13(3):198-201. PubMed ID: 4876631 [No Abstract] [Full Text] [Related]
8. A showdomycin-resistant mutant of Escherichia coli K-12 with altered nucleoside transport character. Komatsu Y; Tanaka K Biochim Biophys Acta; 1972 Nov; 288(2):390-403. PubMed ID: 4563236 [No Abstract] [Full Text] [Related]
9. Puromycin analogs. Synthesis and biological activity of 5'-deoxypuromycin and its aminonucleoside, 6-dimethylamino-9(3'-amin-3',5-dideoxy-beta-D-ribofuranosyl)purine. Almquist RG; Vince R J Med Chem; 1973 Dec; 16(12):1396-8. PubMed ID: 4587855 [No Abstract] [Full Text] [Related]
10. Drastic alteration of ribosomal RNA and ribosomal proteins in showdomycin-resistant Escherichia coli. Beljanski M; Bourgarel P; Beljanski M Proc Natl Acad Sci U S A; 1971 Feb; 68(2):491-5. PubMed ID: 5277106 [TBL] [Abstract][Full Text] [Related]
14. The specific cross-linking of two proteins from the Escherichia coli 30 s ribosomal subunit. Chang FN; Flaks JG J Mol Biol; 1972 Jul; 68(1):177-80. PubMed ID: 4559111 [No Abstract] [Full Text] [Related]
15. Ribose-modified mizoribine analogues: synthesis and biological evaluation. Franchetti P; Pasqualini M; Cappellacci L; Petrelli R; Vita P; Grifantini M Nucleosides Nucleotides Nucleic Acids; 2005; 24(10-12):2023-7. PubMed ID: 16438062 [TBL] [Abstract][Full Text] [Related]
16. Showdomycin and its reactive moiety, maleimide. A comparison in selective toxicity and mechanism of action in vitro. Uehara Y; Fisher JM; Rabinovitz M Biochem Pharmacol; 1980 Aug; 29(16):2199-204. PubMed ID: 7426025 [No Abstract] [Full Text] [Related]
17. 5-Hydroxymethyltubercidin. Synthesis, biological activity, and role in pyrrolopyrimidine biosynthesis. Uematsu T; Suhadolnik RJ J Med Chem; 1973 Dec; 16(12):1405-7. PubMed ID: 4587857 [No Abstract] [Full Text] [Related]
19. Mechanism of action of showdomycin. V. Reduced ability of showdomycin-resistant mutants of Escherichia coli K-12 to take up showdomycin and nucleosides. Komatsu Y J Antibiot (Tokyo); 1971 Dec; 24(12):876-83. PubMed ID: 4946509 [No Abstract] [Full Text] [Related]
20. Mechanisms in protein synthesis. XII. Sites of action of showdomycin in a cell-free polyphenylalanine synthesizing system from human lymphatic tissue: ribosomes and elongation factor TF II. Bermek E; Krämer W; Mönkemeyer H; Matthaei H Biochem Biophys Res Commun; 1970 Sep; 40(6):1311-8. PubMed ID: 4933686 [No Abstract] [Full Text] [Related] [Next] [New Search]